BC
OXFD

Broadfin Capital’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Broadfin Capital’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-374,233
Closed -$4.66M – 64
2018
Q1 		$4.66M Buy
+374,233
New +$4.56M 0.73% 36

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Broadfin Capital's OXFD Position: Q2 2018 in Review

Broadfin Capital sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2018, closing a stake of 374,233 shares — an estimated $4.66M sold.

Broadfin Capital first reported a position in OXFD in Q1 2018 and held it in 1 quarter. The position peaked at $4.66M in Q1 2018. 77 funds tracked by Wall St. Rank hold OXFD as of Q2 2018.

  • Broadfin Capital reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Broadfin Capital sold 374,233 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2018, an estimated $4.66M.
  • Broadfin Capital first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2018 and held it in 1 quarter.
  • Broadfin Capital's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.66M in Q1 2018.
  • 77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2018.

Based on Broadfin Capital's 13F filing for Q2 2018, filed 14 Aug 2018.